Patents by Inventor Yanping DU

Yanping DU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250206797
    Abstract: A human insulin analogue, and a fusion protein thereof and the medical use thereof. The human insulin analogue-Fc fusion protein has ultra-long in-vivo pharmacokinetic properties and can be used for treating metabolic diseases (such as type-I diabetes and type-II diabetes).
    Type: Application
    Filed: March 16, 2023
    Publication date: June 26, 2025
    Inventors: Fangzhou WU, Peng JIANG, Chenxi SHEN, Yanping DU, Renzhi LIU, Yuanyuan LI, Xuchao HUANG, Xugang HE, Lei WANG
  • Publication number: 20230220111
    Abstract: Provided are an anti-FXI/FXIa antibody, an antigen-binding fragment thereof, and a pharmaceutical use thereof, as well as a pharmaceutical composition comprising the anti-FXI/FXIa antibody or the antigen-binding fragment thereof, and a method for treating and preventing a disease, in particular a method for treating thrombosis or thromboembolism-related diseases or disorders.
    Type: Application
    Filed: July 2, 2021
    Publication date: July 13, 2023
    Inventors: Lei WANG, Xugang HE, Jin ZHANG, Xiao LIU, Dongmei HU, Yanping DU, Ran WU, Chenxi SHEN, Yang YANG, Changyong YANG